Itron, Inc. (NASDAQ:ITRI) Receives $131.33 Consensus PT from Brokerages

Itron, Inc. (NASDAQ:ITRI) has been given a consensus recommendation of “Moderate Buy” by the thirteen ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $131.3333.

Several research firms have recently weighed in on ITRI. Robert W. Baird set a $125.00 target price on shares of Itron in a research report on Wednesday, July 29th. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 29th. Needham & Company LLC lifted their price target on Itron from $116.00 to $128.00 and gave the stock a “buy” rating in a research note on Wednesday, July 29th. Stephens reissued an “overweight” rating and issued a $130.00 price objective on shares of Itron in a report on Wednesday, May 20th. Finally, TD Cowen cut their price objective on Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th.

Itron Stock Down 0.4%

ITRI stock opened at $98.43 on Tuesday. Itron has a twelve month low of $77.77 and a twelve month high of $142.00. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $4.31 billion, a P/E ratio of 16.43, a PEG ratio of 1.19 and a beta of 1.30. The firm has a 50 day simple moving average of $90.13 and a 200-day simple moving average of $90.11.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.30. The business had revenue of $562.90 million during the quarter, compared to analyst estimates of $566.34 million. Itron had a net margin of 11.90% and a return on equity of 19.26%. The business’s revenue was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.62 earnings per share. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. On average, equities research analysts predict that Itron will post 6.4 earnings per share for the current fiscal year.

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks added Itron to its Rank #1 (Strong Buy) lists for momentum, value and overall stock selection. The ratings could attract buying interest, although they contrast with Zacks Research’s separate “Hold” rating. Best Momentum Stock to Buy for August 19th
• Positive Sentiment: Zacks Research raised several earnings forecasts, including FY2026 EPS to $6.35 from $5.97, Q3 2026 EPS to $1.55 from $1.52, and FY2027 EPS to $5.90 from $5.86. These revisions indicate improved near-term expectations and provide a potential earnings-related catalyst.
• Neutral Sentiment: The company recently reported adjusted EPS of $1.59, exceeding the $1.29 consensus estimate, while revenue of $562.9 million narrowly missed expectations and declined 7.2% year over year. Itron’s Q3 2026 EPS guidance of $1.50–$1.60 and full-year guidance of $6.30–$6.50 remain broadly consistent with analyst expectations.
• Negative Sentiment: Zacks Research lowered its Q2 2027 EPS estimate to $1.67 from $2.21 and FY2028 EPS to $8.02 from $8.86. The sizable reductions raise concerns about longer-term earnings momentum. In addition, a new article outlines “3 reasons to sell” ITRI and recommends another stock instead, potentially reinforcing bearish sentiment. 3 Reasons to Sell ITRI and 1 Stock to Buy Instead

Insider Transactions at Itron

In other news, SVP John F. Marcolini sold 322 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the transaction, the senior vice president directly owned 24,689 shares in the company, valued at approximately $2,083,010.93. This trade represents a 1.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the completion of the transaction, the senior vice president owned 29,100 shares in the company, valued at approximately $2,455,167. The trade was a 1.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 2,035 shares of company stock worth $171,731. 1.77% of the stock is currently owned by corporate insiders.

Institutional Trading of Itron

A number of institutional investors and hedge funds have recently made changes to their positions in ITRI. Northwestern Mutual Wealth Management Co. increased its position in Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after buying an additional 268 shares during the period. M&T Bank Corp lifted its position in Itron by 10.0% in the 2nd quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company’s stock valued at $282,000 after purchasing an additional 194 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares during the period. Jump Financial LLC acquired a new position in Itron during the 2nd quarter valued at about $1,609,000. Finally, Cerity Partners LLC grew its position in Itron by 10.2% in the 2nd quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company’s stock worth $715,000 after purchasing an additional 503 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.